Publikationen von Hermina Robotka

Garde, B.; Wilson, R. P.; Fell, A.; Cole, N.; Tatayah, V.; Holton, M. D.; Rose, K. A. R.; Metcalfe, R. S.; Robotka, H.; Wikelski, M. et al.; Tremblay, F.; Whelan, S.; Elliott, K. H.; Shepard, E. L. C.: Ecological inference using data from accelerometers needs careful protocols. Methods in Ecology and Evolution 13 (4), S. 813 - 825 (2022)

Wilson, R. P.; Börger, L.; Holton, M. D.; Scantlebury, D. M.; Gómez-Laich, A.; Quintana, F.; Rosell, F.; Graf, P. M.; Williams, H.; Gunner, R. et al.; Hopkins, L.; Marks, N.; Geraldi, N. R.; Duarte, C. M.; Scott, R.; Strano, M. S.; Robotka, H.; Eizaguirre, C.; Fahlman, A.; Shepard, E. L. C.: Estimates for energy expenditure in free-living animals using acceleration proxies: A reappraisal. Journal of Animal Ecology 89 (1), S. 161 - 172 (2020)

Kleiner, D.; Hegyi, G.; Urbanics, R.; Dézsi, L.; Robotka, H.; Fehér, E.; Sárdi, E.; Szebeni, J.; Blázovics, A.: Hepatoprotective liposomal glycyrrhizin in alcoholic liver injury. European Journal of Integrative Medicine 8 (Suppl. 2), S. 23 - 28 (2016)

Szabó, Z.; Gyula, P.; Robotka, H.; Bató, E.; Gálik, B.; Pach, P.; Pekker, P.; Papp, I.; Bihari, Z.: Draft genome sequence of Methylibium sp. strain T29, a novel fuel oxygenate-degrading bacterial isolate from Hungary. Standards in Genomic Sciences 10, 39 (2015)

Milosevits, G.; Rozsnyay, Z.; Kozma, G. T.; Milosevits, J.; Tömöry, G.; Robotka, H.; Rosivall, L.; Szebeni, J.: Flow cytometric analysis of supravesicular structures in doxorubicin-containing pegylated liposomes. Chemistry and Physics of Lipids 165 (4), S. 482 - 487 (2012)

Marosi, M.; Nagy, D.; Farkas, T.; Kis, Z.; Rózsa, E.; Robotka, H.; Fülöp, F.; Vécsei, L.; Toldi, J.: A novel kynurenic acid analogue: A comparison with kynurenic acid. An in vitro electrophysiological study. Journal of Neural Transmission 117 (2), S. 183 - 188 (2010)

Knyihar-Csillik, E.; Mihaly, A.; Krisztin-Peva, B.; Robotka, H.; Szatmari, I.; Fülöp, F.; Toldi, J.; Csillik, B.; Vécsei, L.: The kynurenate analog SZR-72 prevents the nitroglycerol-induced increase of c-fos immunoreactivity in the rat caudal trigeminal nucleus: Comparative studies of the effects of SZR-72 and kynurenic acid. Neuroscience Research 61 (4), S. 429 - 432 (2008)

Robotka, H.; Sas, K.; Agoston, M.; Rózsa, E.; Szénási, G.; Gigler, G.; Vécsei, L.; Toldi, J.: Neuroprotection achieved in the ischaemic rat cortex with L-kynurenine sulphate. Life Sciences 82 (17-18), S. 915 - 919 (2008)

Robotka, H.; Toldi, J.; Vécsei, L.: L-kynurenine: Metabolism and mechanism of neuroprotection. Future Neurology 3 (2), S. 169 - 188 (2008)

Rózsa, E.; Robotka, H.; Nagy, D.; Farkas, T.; Sas, K.; Vécsei, L.; Toldi, J.: The pentylenetetrazole-induced activity in the hippocampus can be inhibited by the conversion of L-kynurenine to kynurenic acid: An in vitro study. Brain Research Bulletin 76 (5), S. 474 - 479 (2008)

Rózsa, E.; Robotka, H.; Vécsei, L.; Toldi, J.: The Janus-face kynurenic acid. Journal of Neural Transmission 115 (8), S. 1087 - 1091 (2008)

Sas, K.; Robotka, H.; Rózsa, E.; Agoston, M.; Szénási, G.; Gigler, G.; Marosi, M.; Kis, Z.; Farkas, T.; Vécsei, L. et al.; Toldi, J.: Kynurenine diminishes the ischemia-induced histological and electrophysiological deficits in the rat hippocampus. Neurobiology of Disease 32 (2), S. 302 - 308 (2008)

Németh, H.; Robotka, H.; Toldi, J.; Vécsei, L.: Kynurenines in the central nervous system: Recent developments. Central Nervous System Agents in Medical Chemistry 7, S. 45 - 56 (2007)

Sas, K.; Robotka, H.; Toldi, J.; Vécsei, L.: Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders. Journal of the Neurological Sciences 257 (1-2), S. 221 - 239 (2007)

Marosi, M.; Rákos, G.; Robotka, H.; Németh, H.; Sas, K.; Kis, Z.; Farkas, T.; Lür, G.; Vécsei, L.; Toldi, J.: Hippocampal (CA1) activities in Wistar rats from different vendors: Fundamental differences in acute ischemia. Journal of Neuroscience Methods 156 (1-2), S. 231 - 235 (2006)

Robotka, H.; Németh, H.; Somlai, C.; Vécsei, L.; Toldi, J.: Systemically administered glucosamine-kynurenic acid, but not pure kynurenic acid, is effective in decreasing the evoked activity in area CA1 of the rat hippocampus. European Journal of Pharmacology 513 (1-2), S. 75 - 80 (2005)

Szegedi, V.; Fülöp, L.; Farkas, T.; Rózsa, E.; Robotka, H.; Kis, Z.; Penke, Z.; Horváth, S.; Molnár, Z.; Datki, Z. et al.; Soós, K.; Toldi, J.; Budai, D.; Zarándi, M.; Penke, B.: Pentapeptides derived from Aβ1–42 protect neurons from the modulatory effect of Aβ fibrils: An in vitro and in vivo electrophysiological study. Neurobiology of Disease 18 (3), S. 499 - 508 (2005)

Németh, H.; Robotka, H.; Kis, Z.; Rózsa, E.; Janáky, T.; Somlai, C.; Marosi, M.; Farkas, T.; Toldi, J.; Vécsei, L.: Kynurenine administered together with probenecid markedly inhibits pentylenetetrazol-induced seizures. An electrophysiological and behavioural study. Neuropharmacology 47, S. 916 - 925 (2004)